DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Maindrault-Goebel F, Lledo G, Chibaudel B. et al.
Final results of OPTIMOX2, a large randomized phase II study of maintenance therapy or chemotherapy-free intervals (CFI) after FOLFOX in patients with metastatic colorectal cancer (MRC): A GERCOR study.
J Clin Oncol 2007; 25: 18S (Abstr 4013)-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.